Inventor · disambiguated record
James Hendrix
Also filed as: HENDRIX JAMES · HENDRIX JAMES A
8 granted patents·5 pending applications·56 citations·filing 2002–2025
83Inventor score
Top patents by PatentIndex Score
13 records- 0192US7772252B2Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligandsAVENTIS PHARMA INC·Filed 2009·Granted Aug 10, 2010·22 cites·20 claims
- 0288US7253165B2Benzisoxazolyl-, pyridoisoxazolyl-and benzthienyl-phenoxy derivatives useful as D4 antagonistsAVENTIS PHARMA INC·Filed 2004·Granted Aug 7, 2007·24 cites·211 claims
- 0381US11306075B2Benzofuran, benzothiophene, and indole analogs that inhibit the formation of tau oligomers and their method of useOLIGOMERIX INC·Filed 2017·Granted Apr 19, 2022·2 cites·9 claims
- 0476US11472776B2Quinazolinones that inhibit the formation of tau oligomers and their method of useOLIGOMERIX INC·Filed 2017·Granted Oct 18, 2022·1 cites·8 claims
- 0576US2025304565A1Novel benzofuran, benzothiophene, and indole analogs that inhibit the formation of tau oligomers and their method of useOLIGOMERIX INC·Filed 2025·Application pending·0 cites
- 0674US7550469B2Heterocyclic amide derivatives and their use as dopamine D3 receptor ligandsAVENTIS PHARMA INC·Filed 2006·Granted Jun 23, 2009·3 cites·5 claims
- 0771US12331043B2Benzofuran, benzothiophene, and indole analogs that inhibit the formation of tau oligomers and their method of useOLIGOMERIX INC·Filed 2022·Granted Jun 17, 2025·0 cites·5 claims
- 0869US7186724B2Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligandsAVENTIS PHARMA INC·Filed 2004·Granted Mar 6, 2007·4 cites·40 claims
- 0959US2024158357A1Novel quinazolinones that inhibit the formation of tau oligomers and their method of useOLIGOMERIX INC·Filed 2022·Application pending·0 cites
- 1057US7521445B2Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligandsAVENTIS PHARMA INC·Filed 2007·Granted Apr 21, 2009·0 cites·19 claims
- 1150US2005107389A1Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligandsAVENTIS PHARMA INC·Filed 2004·Application pending·0 cites
- 1243US2004030137A1Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligandsFiled 2002·Application pending·0 cites
- 1334US2003229066A1Novel heterocyclic urea derivatives and their use as dopamine D3 receptor ligandsFiled 2002·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →